Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Cancer. 2010 Jul 1;116(13):3276–3284. doi: 10.1002/cncr.25190

Table 3.

Scoring of immunohistochemistry results

Case c-p65 n-p65 c-p50 n-p50 RelB IKKa IKKe IKKb MMP9
1 0 3 3 0 2 2 0 2 3
2 4 3 2 0 3 4 0 3 4
3 2 3 3 0 3 0 0 4 0
4 3 3 2 4 4 4 0 3 4
5 0 1 4 0 2 3 0 4 3
6 0 3 2 0 0 3 0 4 0
7 3 1 1 0 2 2 0 4 2
8 0 2 2 0 0 2 0 4 1
9 3 4 4 0 4 4 0 4 4
11 2 1 0 0 2 3 0 0 4
12 4 3 3 0 4 4 0 3 4
13 3 1 4 0 3 1 0 3 1
14 0 3 0 0 1 0 0 4 1
15 1 3 3 0 1 1 0 3 3
16 1 3 3 0 2 4 0 4 0
17 0 3 2 0 2 3 0 4 2
18 1 4 4 0 3 4 0 4 3
19 4 3 2 0 4 4 0 4 4
20 3 3 4 0 3 3 0 3 4
21 3 3 4 0 4 4 1 3 4
27 0 1 3 0 0 2 0 4 3
29 0 3 3 0 0 2 0 4 0
30 2 1 1 1 4 4 0 1 3
31 4 4 4 0 3 4 0 4 3
32 3 3 3 0 4 3 0 3 2
34 1 3 0 0 1 3 0 2 4
35 0 2 1 0 1 2 0 3 1
36 0 2 3 0 2 1 0 3 4
40 4 3 2 0 4 4 0 4 3
41 4 3 4 0 4 3 0 2 4
42 0 1 1 0 3 3 0 4 3
43 4 1 4 0 nd 4 2 nd nd
45 0 4 3 0 3 3 0 1 1

Staining was scored on a scale of 0–4: 0=no staining, 1=1–5%, 2=6–25%, 3=26–75%, 4=76–100% of tumor cells; nd = not done; c, cytoplasmic staining; n, nuclear staining; no designation indicates cytoplasmic staining only.